29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Polymer microspheres for controlled drug release.

      1 ,
      International journal of pharmaceutics
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Polymer microspheres can be employed to deliver medication in a rate-controlled and sometimes targeted manner. Medication is released from a microsphere by drug leaching from the polymer or by degradation of the polymer matrix. Since the rate of drug release is controlled by these two factors, it is important to understand the physical and chemical properties of the releasing medium. This review presents the methods used in the preparation of microspheres from monomers or from linear polymers and discusses the physio-chemical properties that affect the formation, structure, and morphology of the spheres. Topics including the effects of molecular weight, blended spheres, crystallinity, drug distribution, porosity, and sphere size are discussed in relation to the characteristics of the release process. Added control over release profiles can be obtained by the employment of core-shell systems and pH-sensitive spheres; the enhancements presented by such systems are discussed through literature examples.

          Related collections

          Author and article information

          Journal
          Int J Pharm
          International journal of pharmaceutics
          Elsevier BV
          0378-5173
          0378-5173
          Sep 10 2004
          : 282
          : 1-2
          Affiliations
          [1 ] Département de chimie, Université de Montréal, C.P. 6128, Succursale Centre-ville, Montréal, Que., H3C 3J7, Canada.
          Article
          S0378517304002492
          10.1016/j.ijpharm.2004.04.013
          15336378
          04940636-cb4d-490c-8545-3589ace2de31
          History

          Comments

          Comment on this article

          Related Documents Log